Alpha Mark Advisors, LLC Stealth Bio Therapeutics Corp Put Options Transaction History
Alpha Mark Advisors, LLC
- $290 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MITO
# of Institutions
1Shares Held
2.94KCall Options Held
0Put Options Held
0About Stealth BioTherapeutics Corp
- Ticker MITO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,548,600
- Description
- Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...